(Q34563239)

3 August 2017

title

High CA 19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature (English)

1 reference

3 August 2017

author name string

Konstantinos H. Katsanos

1

1 reference

3 August 2017

Margarita Kitsanou

2

1 reference

3 August 2017

Dimitrios K. Christodoulou

3

1 reference

3 August 2017

Epameinondas V. Tsianos

4

1 reference

3 August 2017

publication date

1 March 2002

1 reference

European Journal of Internal Medicine

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

132-135

1 reference

Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

Elevated serum levels of tumor marker CA19-9 in acute cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

A case of inflammatory pseudotumor of the liver causing elevated serum CA19-9 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

Serum levels of carbohydrate antigenic determinant (CA 19.9) in obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

High coincidence of Mirizzi syndrome and gallbladder carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900002-X

7 January 2021

10.1016/S0953-6205(02)00002-X

Identifiers

DOI

1 reference

3 August 2017

1 reference